A virtual cell system prototyping for development and validation of skin lightening actives: Correlation with ex vivo and in vivo results

        Reducing uneven pigmentation, a hallmark of aging changes in ethnic population, is of interest to dermatologists and their patients. For the cosmetic industry, meeting consumers' expectations in this area requires more efficacy than that provided by currently marketed tyrosinase inhibitors.
        To read this article in full you will need to make a payment
        AAD Member Login
        AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features

        Purchase one-time access:

        Already a print subscriber? Claim online access
        Already an online subscriber? Sign in
        Institutional Access: Sign in to ScienceDirect